In the last trading session, 1.2 million Context Therapeutics Inc (NASDAQ:CNTX) shares changed hands as the company’s beta touched 2.19. With the company’s per share price at $1.85 changed hands at $0.1 or 5.71% during last session, the market valuation stood at $29.54M. CNTX’s last price was a discount, traded about -1.62% off its 52-week high of $1.88. The share price had its 52-week low at $0.47, which suggests the last value was 74.59% up since then. When we look at Context Therapeutics Inc’s average trading volume, we note the 3-month average coming to 496.20K.

Context Therapeutics Inc (NASDAQ:CNTX) trade information

Instantly CNTX was in green as seen at the end of in last trading. With action 31.20%, the performance over the past five days has been green. The jump to weekly highs of 1.8800 added 5.71% to the stock’s daily price. The company’s shares are showing year-to-date upside of 63.72%, with the 5-day performance at 31.20% in the green. However, in the 30-day time frame, Context Therapeutics Inc (NASDAQ:CNTX) is 44.53% up.

Context Therapeutics Inc (CNTX) estimates and forecasts

Data shows that the Context Therapeutics Inc share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 66.67% over the past 6 months, a 8.00% in annual growth rate that is considerably lower than the industry average of 11.70%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -26.70%. The 2024 estimates are for Context Therapeutics Inc earnings to increase by 29.33%.

CNTX Dividends

Context Therapeutics Inc is expected to release its next quarterly earnings report in June.